Articles dans des revues avec comité de lecture (51)
  1. 33. Merlos, R., Amighi, K., & Wauthoz, N. (2014). Recent developments in inhaled triazoles against invasive pulmonary aspergillosis. Current Fungal Infection Reports, 8(4), 331-342. doi:10.1007/s12281-014-0199-5
  2. 34. Wauthoz, N., & Amighi, K. (2014). Phospholipids in pulmonary drug delivery. European journal of lipid science and technology, 116(9), 1114-1128. doi:10.1002/ejlt.201300368
  3. 35. Duret, C., Merlos, R., Wauthoz, N., Sebti, T., Vanderbist, F., & Amighi, K. (2014). Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention. European journal of pharmaceutics and biopharmaceutics, 86(1), 46-54. doi:10.1016/j.ejpb.2013.03.005
  4. 36. Bury, M., Novo-Uzal, E., Andolfi, A., Cimini, S., Wauthoz, N., Heffeter, P., Lallemand, B., Avolio, F., Delporte, C., Cimmino, A., Dubois, J., Van Antwerpen, P., Zonno, M. C., Vurro, M., Poumay, Y., Berger, W., Evidente, A., De Gara, L., Kiss, R., & Locato, V. (2013). Ophiobolin A, a sesterterpenoid fungal phytotoxin, displays higher in vitro growth-inhibitory effects in mammalian than in plant cells and displays in vivo antitumor activity. International journal of oncology, 43(2), 575-585. doi:10.3892/ijo.2013.1979
  5. 37. Mathieu, V., Wauthoz, N., Lefranc, F., Niemann, H., Amighi, K., Kiss, R., & Proksch, P. (2013). Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects. Molecules, 18(3), 3543-3561. doi:10.3390/molecules18033543
  6. 38. Lallemand, B., Ouedraogo, M., Wauthoz, N., Lamkami, T., Mathieu, V., Jabin, I., Amighi, K., Kiss, R., Dubois, J., & Goole, J. (2013). Synthesis and plasma pharmacokinetics in CD-1 mice of a 18β-glycyrrhetinic acid derivative displaying anti-cancer activity. Journal of Pharmacy and Pharmacology, 65(3), 402-410. doi:10.1111/j.2042-7158.2012.01603.x
  7. 39. Van Woensel, M., Wauthoz, N., Rosiere, R., Amighi, K., Mathieu, V., Lefranc, F., Van Gool, S. W., & De Vleeschouwer, S. (2013). Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? Cancers (Basel), 5(3), 1020-1048. doi:10.3390/cancers5031020
  8. 40. Duret, C., Wauthoz, N., Sebti, T., Vanderbist, F., & Amighi, K. (2012). New Inhalation-Optimized Itraconazole Nanoparticle-Based Dry Powders for the Treatment of Invasive Pulmonary Aspergillosis. International journal of nanomedicine, 7, 5475–5489. doi:10.2147/IJN.S34091
  9. 41. Duret, C., Wauthoz, N., Merlos, R., Goole, J., Maris, C., Roland, I., Sebti, T., Vanderbist, F., & Amighi, K. (2012). In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. European journal of pharmaceutics and biopharmaceutics, 81(3), 627-634. doi:10.1016/j.ejpb.2012.04.004
  10. 42. Lamoral-Theys, D., Wauthoz, N., Heffeter, P., Mathieu, V., Jungwirth, U., Lefranc, F., Neve, J., Dubois, J., Dufrasne, F., Amighi, K., Berger, W., Gailly, P., & Kiss, R. (2012). Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca 2+ release. Journal of Cellular and Molecular Medicine, 16(7), 1421-1434. doi:10.1111/j.1582-4934.2011.01403.x.
  11. 43. Duret, C., Wauthoz, N., Sebti, T., Vanderbist, F., & Amighi, K. (2012). New Respirable and Fast Dissolving Itraconazole Dry Powder Composition for the Treatment of Invasive Pulmonary Aspergillosis. Pharmaceutical research, 29(10), 2845-2859. doi:10.1007/s11095-012-0779-4
  12. 44. Duret, C., Wauthoz, N., Sebti, T., Vanderbist, F., & Amighi, K. (2012). Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties. International journal of pharmaceutics, 428(1-2), 103-113. doi:10.1016/j.ijpharm.2012.03.002
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>